9 March 2021
16:00-17:00 CET
online
Continuing our successful online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.
Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe.
A one-on-one interview with Professor Guido Rasi, former Executive Director, European Medicines Agency (EMA).
Professor Rasi will talk about about his time at the helm of Europe’s top regulator; the power balance between pharma and governments; the impact of the pandemic on the pharmaceutical regulatory framework and the innovation landscape and trends in Europe and beyond.
#A2MDialogues
Professor Guido Rasi
Former Executive Director
European Medicines Agency
Interviewed by
Yannis Natsis,
Policy Manager, Universal Access and Affordable Medicines
European Public Health Alliance
Catch up on EPHA’s other #A2MDialogues below
Getting it right: Recommendations for a European BARDA
8 December 2020
The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicines
25 November 2020
Pharma & COVID19: Winners, losers, prospects
19 November 2020
The EU's IP strategy: Enabler or barrier?
27 October 2020
Unleashing meaningful innovation through regulatory reform
19 October 2020
